Global Safety Syringes Market is valued at approximately USD 7096.94 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.5% during the forecast period 2023-2030.

The global safety syringes market, valued at approximately USD 7.1 billion in 2022, is projected to grow at a steady compound annual growth rate (CAGR) of over 4.5% during the forecast period from ...

The North America Syringe Infusion Pumps Market is projected to grow from USD 645.1 million in 2024 to USD 1.04 billion by ...

MIT engineers have developed a tiny implantable device that could revolutionize emergency treatment for people with Type 1 ...

Yesafili, a biosimilar to Eylea, received Health Canada's approval, marking the first such approval in Canada. Indicated for ...

This is because it is very hard to control blood sugar levels in space, where there is no gravity. But now, the Ax-4 mission ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and Ozempic for weight loss and lowering blood sugar.

Embecta Corp. (NASDAQ:EMBC) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On May 23, Mizuho lowered ...

The global enteral feeding devices market, valued at US$2,807.9 million in 2024, stood at US$2,965.1 million in 2025 and is ...

For people with type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Counterfeit drugs, including cosmetic injectables, weight-loss drugs, and ivermectin tablets, have been seized at Australia’s borders, prompting a fresh round of safety alerts from the Therapeutic ...